GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: An evidence-based meta-analysis

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Zhuo, Xianlu ^a,b   Cai, Lei ^a   Xiang, Zhaolan ^a   Li, Qi ^a   Zhang, Xueyuan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CASE CONTROL STUDY; EVIDENCE BASED PRACTICE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GSTMI GENE; GSTTI GENE; HUMAN; NASOPHARYNX CANCER; ONCOGENE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY ANALYSIS; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; METABOLISM; NASOPHARYNX TUMOR; NUCLEIC ACID DATABASE;

GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

CASE-CONTROL STUDIES; DATABASES, NUCLEIC ACID; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 64649091715     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-46     Document Type: Article

References (35)

1. Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. CL Lin WF Lo TH Lee Y Ren SL Hwang YF Cheng CL Chen YS Chang SP Lee AB Rickinson PK Tam, Cancer Res 2002 62 6952 6958 12460912
2. Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. JD O'Neil TJ Owen VH Wood KL Date R Valentine MB Chukwuma JR Arrand CW Dawson LS Young, J Gen Virol 2008 89 2833 2842 10.1099/vir.0.2008/003392-0 18931081
3. Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. YJ Cheng A Hildesheim MM Hsu IH Chen LA Brinton PH Levine CJ Chen CS Yang, Cancer Causes Control 1999 10 201 207 10.1023/A:1008893109257 10454065
4. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. J Schneider U Bernges M Philipp HJ Woitowitz, Cancer Lett 2004 208 65 74 10.1016/j.canlet.2004.01.002 15105047
5. Rational inferences about departures from Hardy-Weinberg equilibrium. JK Wittke-Thompson A Pluzhnikov NJ Cox, Am J Hum Genet 2005 76 967 986 15834813 10.1086/430507
6. Was Thomas Wolfe a borderline? D Rosenthal, Schizophr Bull 1979 5 87 94 375384
7. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. V Nazar-Stewart TL Vaughan RD Burt C Chen M Berwick GM Swanson, Cancer Epidemiol Biomarkers Prev 1999 8 547 551 10385146
8. Relationship between GSTM 1 gene polymorphism and genetic susceptibility in nasopharyngeal carcinoma. SJ Da B Liang HL Wu LL Guan, The Practical Journal of Cancer (Chinese) 2002 17 617 619
9. Associations of GSTM1 and GSTT1 polymorphisms with nasopharyngeal cancer risk. ZL Liao Zl Deng YP Wei KS Xie B Zhang XM Dai CS Xu, Journal of Guangxi Medical University (Chinese) 2005 22 372 374
10. Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma. D Tiwawech P Srivatanakul A Karalak T Ishida, Asian Pac J Cancer Prev 2005 6 270 275 16235985
11. No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan. YJ Cheng YC Chien A Hildesheim MM Hsu IH Chen J Chuang J Chang YD Ma CT Luo WL Hsu HH Hsu H Huang JF Chang CJ Chen CS Yang, Cancer Epidemiol Biomarkers Prev 2003 12 179 180 12582034
12. Frequent genetic deletion of detoxifying enzyme GSTM1 and GSTT1 genes in nasopharyngeal carcinoma patients in Guangxi Province, China. ZL Deng YP Wei Y Ma, Zhonghua Zhong Liu Za Zhi 2004 26 10 598 600 15634519
13. Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience. K Bendjemana M Abdennebi S Gara A Jmal A Ghanem S Touati H Boussen A Ladgham F Guemira, Bull Cancer 2006 93 297 302 16567317
14. GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese. X Guo SJ O'Brien Y Zeng GW Nelson CA Winkler, Cancer Epidemiol Biomarkers Prev 2008 17 1760 1763 10.1158/1055-9965.EPI-08-0149 18628429
15. Measuring inconsistency in meta-analyses. JP Higgins SG Thompson JJ Deeks DG Altman, BMJ 2003 327 557 560 12958120 10.1136/bmj.327.7414.557
16. Assessing the influence of a single study in the meta-analysis estimate. A Tobias, Stata Techn Bull 1999 8 15 17
17. Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis. JW Sull H Ohrr DR Kang CM Nam, Yonsei Med J 2004 45 683 689 15344211
18. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. X Shi S Zhou Z Wang Z Zhou Z Wang, Lung Cancer 2008 59 155 163 10.1016/j.lungcan.2007.08.004 17900751
19. CYP1A1 and GSTM1 Polymorphisms and Oral Cancer Risk: Association Studies Via Evidence-Based Meta-Analyses. W Zhuo Y Wang X Zhuo Y Zhu W Wang B Zhu D Li Z Chen, Cancer Invest 2009 27 86 95 10.1080/07357900802146170 19160101
20. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. DL White D Li Z Nurgalieva HB El-Serag, Am J Epidemiol 2008 167 377 389 10.1093/aje/kwm315 18065725
21. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. R Lai L Crevier L Thabane, Cancer Epidemiol Biomarkers Prev 2005 14 1784 1790 10.1158/1055-9965.EPI-05-0105 16030117
22. Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. G La Torre S Boccia G Ricciardi, Cancer Lett 2005 217 53 60 10.1016/j.canlet.2004.08.020 15596296
23. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. CX Yang K Matsuo ZM Wang K Tajima, World J Gastroenterol 2005 11 2531 2538 15849806
24. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. C Ntais A Polycarpou JP Ioannidis, Cancer Epidemiol Biomarkers Prev 2005 14 176 181 15668493
25. GST genotypes and lung cancer susceptibility in Asian populations with indoor air pollution exposures: a meta-analysis. HD Hosgood SI Berndt Q Lan, Mutat Res 2007 636 134 143 17428724 10.1016/j.mrrev.2007.02.002
26. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. M Saadat, Cancer Sci 2006 97 505 509 10.1111/j.1349-7006.2006.00207.x 16734729
27. Relationship between metabolic enzyme polymorphism and colorectal cancer. K Chen QT Jiang HQ He, World J Gastroenterol 2005 11 331 335 15637738
28. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Z Ye H Song, Eur J Cancer 2005 41 980 989 10.1016/j.ejca.2005.01.014 15862746
29. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. M Hashibe P Brennan RC Strange R Bhisey I Cascorbi P Lazarus MB Oude Ophuis S Benhamou WD Foulkes T Katoh C Coutelle M Romkes L Gaspari E Taioli P Boffetta, Cancer Epidemiol Biomarkers Prev 2003 12 1509 1517 14693745
30. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. FD Vogl E Taioli C Maugard W Zheng LF Pinto C Ambrosone FF Parl V Nedelcheva-Kristensen TR Rebbeck P Brennan P Boffetta, Cancer Epidemiol Biomarkers Prev 2004 13 1473 1479 15342448
31. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. HM Bolt R Thier, Curr Drug Metab 2006 7 613 628 10.2174/138920006778017786 16918316
32. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. V Harth M Schafer J Abel L Maintz T Neuhaus M Besuden R Primke A Wilkesmann R Thier H Vetter YD Ko T Bruning HM Bolt K Ickstadt, J Toxicol Environ Health A 2008 71 887 897 10.1080/ 15287390801988160 18569591
33. Bias in meta-analysis detected by a simple, graphical test. M Egger G Davey Smith M Schneider C Minder, BMJ 1997 315 629 634 9310563
34. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. N Terrin CH Schmid J Lau, J Clin Epidemiol 2005 58 894 901 10.1016/j.jclinepi.2005.01.006 16085192
35. The case of the misleading funnel plot. J Lau JP Ioannidis N Terrin CH Schmid I Olkin, BMJ 2006 333 597 600 16974018 10.1136/bmj.333.7568.597